Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Proteomic Profiling to Differentiate Pancreatic and Biliary Adenocarcinomas

NCT06776146 is registered in ClinicalTrials.gov with University Hospital, Bordeaux as lead sponsor.

NCT NCT06776146
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06776146 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Proteomic Profiling to Differentiate Pancreatic and Biliary Adenocarcinomas
Lead sponsor
University Hospital, Bordeaux
Phase
Observational
Overall status
Not yet recruiting
Start date
September 30, 2025
Completion date
March 31, 2026
Enrollment
28 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic adenocarcinoma